Ocusan Dry Eyes 0.4 % / 0.3 % Ophthalmic Suspension
RxNorm 2369388

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2369388 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Ocusan Dry Eyes 0.4 % / 0.3 % Ophthalmic Suspension.

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
Ocusan Dry Eyes (polyethylene glycol 400 0.4 % / propylene glycol 0.3 % ) Ophthalmic Suspension
AUI:12398262
View
PSN
Ocusan Dry Eyes 0.4 % / 0.3 % Ophthalmic Suspension
AUI:12398261
View
SBD
Polyethylene glycol 400 4 mg/ML / propylene glycol 3 mg/ML Ophthalmic Suspension [Ocusan Dry Eyes]
AUI:12398256
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SY

Synonym (SY):
Ocusan Dry Eyes (polyethylene glycol 400 0.4 % / propylene glycol 0.3 % ) Ophthalmic Suspension
(Atom ID: 12398262)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Ocusan Dry Eyes (polyethylene glycol 400 0.4 % / propylene glycol 0.3 % ) Ophthalmic Suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2369388
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12398262
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2369388
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
PSN

Prescribable Name (PSN):
Ocusan Dry Eyes 0.4 % / 0.3 % Ophthalmic Suspension
(Atom ID: 12398261)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Ocusan Dry Eyes 0.4 % / 0.3 % Ophthalmic Suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2369388
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12398261
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2369388
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SBD

Semantic Branded Drug (SBD):
Polyethylene glycol 400 4 mg/ML / propylene glycol 3 mg/ML Ophthalmic Suspension [Ocusan Dry Eyes]
(Atom ID: 12398256)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
polyethylene glycol 400 4 MG/ML / propylene glycol 3 MG/ML Ophthalmic Suspension [Ocusan Dry Eyes]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2369388
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12398256
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
2369388
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN ACTIVATED
04/29/2025
Date the RxNorm atom was reactivated
RXN AI
{477590} 34693
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{477591} 8514
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{477590} 34693
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{477591} 8516
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
4 MG/ML / 3 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{477590} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{477591} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXN OBSOLETED
01/28/2025
Date the RxNorm atom became obsolete
RXTERM FORM
Susp
The RxTerm dose form name for this drug